NASDAQ:ADUS Addus HomeCare (ADUS) Stock Price, News & Analysis $115.82 -1.77 (-1.51%) As of 02:11 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Addus HomeCare Stock (NASDAQ:ADUS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Addus HomeCare alerts:Sign Up Key Stats Today's Range$115.77▼$117.2450-Day Range$90.71▼$119.6852-Week Range$87.95▼$124.43Volume47,379 shsAverage Volume243,534 shsMarket Capitalization$2.16 billionP/E Ratio20.38Dividend YieldN/APrice Target$130.88Consensus RatingModerate Buy Company Overview Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life. The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists. Addus HomeCare also provides private duty nursing, hospice and palliative care, and specialized programs for chronic conditions, Alzheimer’s disease, and pediatric therapy needs. Telehealth solutions and care coordination tools are integrated to enhance clinical oversight and patient engagement. Tracing its roots to operations established in 1970, Addus HomeCare has grown through strategic acquisitions and organic expansion to serve clients in approximately 30 states. Headquartered in Charlotte, North Carolina, the company leverages a veteran executive leadership team with deep expertise in home health care delivery, regulatory compliance, and operational excellence. Addus HomeCare remains committed to advancing community-based services that enable individuals to “age in place” with dignity and comfort.AI Generated. May Contain Errors. Read More Addus HomeCare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreADUS MarketRank™: Addus HomeCare scored higher than 71% of companies evaluated by MarketBeat, and ranked 310th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingAddus HomeCare has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 7 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialAddus HomeCare has a consensus price target of $130.88, representing about 12.8% upside from its current price of $116.05.Amount of Analyst CoverageAddus HomeCare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Addus HomeCare's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth7.47% Earnings GrowthEarnings for Addus HomeCare are expected to grow by 7.47% in the coming year, from $6.29 to $6.76 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Addus HomeCare is 20.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.58.Price to Earnings Ratio vs. SectorThe P/E ratio of Addus HomeCare is 20.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 269.56.Price to Earnings Growth RatioAddus HomeCare has a PEG Ratio of 1.59. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAddus HomeCare has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Addus HomeCare's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.73% of the float of Addus HomeCare has been sold short.Short Interest Ratio / Days to CoverAddus HomeCare has a short interest ratio ("days to cover") of 5.14.Change versus previous monthShort interest in Addus HomeCare has recently decreased by 3.78%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAddus HomeCare does not currently pay a dividend.Dividend GrowthAddus HomeCare does not have a long track record of dividend growth. News and Social Media2.4 / 5News Sentiment0.90 News SentimentAddus HomeCare has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Addus HomeCare this week, compared to 4 articles on an average week. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $73,506.00 in company stock.Percentage Held by Insiders4.10% of the stock of Addus HomeCare is held by insiders.Percentage Held by Institutions95.35% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Addus HomeCare's insider trading history. Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADUS Stock News HeadlinesAddus HomeCare replaces COO Heather Dixon with interim return of Brad BickhamAugust 10, 2026 | msn.comAddus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim BasisAugust 10, 2026 | finance.yahoo.comWhy I'm sending this one to my own familyBehind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congressional session, two executive orders signed in a single afternoon, and a quiet government stake in a $20 company have pushed Dylan Jovine to release his most urgent briefing yet. Inside: the day U.S. intelligence has reportedly flagged, a 41-year-old strategy tied to a wave of new millionaires, and growing warnings from the World Economic Forum about a two-tier financial system taking shape.August 14 at 1:00 AM | Behind the Markets (Ad)Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL) and Addus Homecare (ADUS)August 6, 2026 | theglobeandmail.comBarclays Remains a Sell on Addus Homecare (ADUS)August 6, 2026 | theglobeandmail.comAddus HomeCare Q2 Momentum Seen Continuing, RBC SaysAugust 5, 2026 | finance.yahoo.comAddus outlines full-year adjusted EBITDA margin of 12%-13% while pursuing larger acquisitionsAugust 4, 2026 | seekingalpha.comAddus HomeCare Corporation (ADUS) Q2 2026 Earnings Call TranscriptAugust 4, 2026 | seekingalpha.comSee More Headlines ADUS Stock Analysis - Frequently Asked Questions How have ADUS shares performed this year? Addus HomeCare's stock was trading at $107.39 on January 1st, 2026. Since then, ADUS shares have increased by 8.1% and is now trading at $116.0450. How were Addus HomeCare's earnings last quarter? Addus HomeCare Corporation (NASDAQ:ADUS) released its quarterly earnings data on Monday, August, 3rd. The company reported $1.73 EPS for the quarter, beating analysts' consensus estimates of $1.70 by $0.03. The company's quarterly revenue was up 8.0% on a year-over-year basis. Read the conference call transcript. When did Addus HomeCare IPO? Addus HomeCare (ADUS) raised $65 million in an IPO on Thursday, October 22nd 2009. The company issued 5,400,000 shares at a price of $11.00-$13.00 per share. Who are Addus HomeCare's major shareholders? Addus HomeCare's top institutional shareholders include BlackRock Inc. (18.35%), Wasatch Advisors LP (3.65%), TimesSquare Capital Management LLC (1.68%) and William Blair Investment Management LLC (0.94%). Insiders that own company stock include R Dirk Allison, Brian Poff, Darby Anderson, Heather Brianne Dixon, Sean Gaffney, Roberton James Stevenson, Monica Raines, Cliff Donald Blessing, David W Tucker, Michael D Wattenbarger, Veronica Hill-Milbourne and Esteban Lopez. View institutional ownership trends. How do I buy shares of Addus HomeCare? Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Addus HomeCare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Addus HomeCare investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), Eli Lilly and Company (LLY) and ServiceNow (NOW). Company Calendar Last Earnings8/03/2026Today8/14/2026Next Earnings (Estimated)11/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 ADUS's financial health is in the Green zone, according to TradeSmith. ADUS has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:ADUS CIK1468328 Webwww.addus.com Phone(469) 535-8200Fax630-487-2707Employees50,659Year Founded1979Price Target and Rating Average Price Target for Addus HomeCare$130.88 High Price Target$145.00 Low Price Target$96.00 Potential Upside/Downside+12.3%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$5.70 Trailing P/E Ratio20.46 Forward P/E Ratio18.53 P/E Growth1.59Net Income$95.91 million Net Margins7.13% Pretax Margin9.53% Return on Equity9.96% Return on Assets7.62% Debt Debt-to-Equity Ratio0.05 Current Ratio1.69 Quick Ratio1.69 Sales & Book Value Annual Sales$1.42 billion Price / Sales1.53 Cash Flow$6.41 per share Price / Cash Flow18.18 Book Value$61.48 per share Price / Book1.90Miscellaneous Outstanding Shares18,670,000Free Float17,908,000Market Cap$2.18 billion OptionableOptionable Beta0.87 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:ADUS) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersSMX Could Turn Proof Technology into Major Profit!SMX (Security Matters) PLC embeds invisible molecular markers into materials like plastics, metals, fuels, and...Smallcaps Daily | SponsoredA Wall Street Veteran's Weekly Options Strategy ExplainedA former Merrill Lynch and Vanguard advisor spent 25 years watching one weekly options play generate consisten...Base Camp Trading | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredWhy I'm sending this one to my own familyBehind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...Behind the Markets | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
